Shuo Lin Selected Research

L 158809

9/2012

Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuo Lin Research Topics

Disease

19	Neoplasms (Cancer) 12/2018 - 06/2007
7	Type 2 Diabetes Mellitus (MODY) 01/2020 - 06/2015
5	Muscular Diseases (Myopathy) 01/2020 - 12/2011
5	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 12/2019 - 12/2008
5	Anemia 12/2019 - 09/2002
4	Atrophy 01/2020 - 08/2011
4	Inflammation (Inflammations) 01/2018 - 09/2012
4	Muscular Dystrophies (Muscular Dystrophy) 01/2017 - 03/2007
3	Insulin Resistance 01/2021 - 11/2015
3	Carcinogenesis 10/2014 - 02/2003
3	Leukemia 07/2010 - 02/2003
2	Muscular Atrophy (Muscle Atrophy) 01/2020 - 03/2013
2	Sarcopenia 01/2020 - 01/2014
2	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 01/2018
2	Hypertrophy 01/2020 - 03/2013
2	Wounds and Injuries (Trauma) 10/2019 - 09/2019
2	Body Weight (Weight, Body) 07/2019 - 11/2015
2	Perinatal Death 01/2019 - 07/2007
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2019 - 04/2016
2	Ischemia 01/2019 - 11/2012
2	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2018 - 03/2011
2	Congenital Abnormalities (Deformity) 01/2018 - 09/2008
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2014 - 10/2011
2	Fibrosis (Cirrhosis) 09/2012 - 08/2011
2	Melanoma (Melanoma, Malignant) 09/2012 - 01/2011
2	Myasthenia Gravis 08/2011 - 03/2011
1	Graves Ophthalmopathy 12/2020
1	Graves Disease (Basedow Disease) 12/2020
1	Chromosome 5q Deletion Syndrome 12/2019
1	Reinjuries 12/2019
1	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2019
1	Myocardial Infarction 10/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2019
1	Ascites 09/2019
1	Seroma 09/2019
1	Hepatic Encephalopathy 09/2019
1	Sepsis (Septicemia) 09/2019
1	Renal Insufficiency (Renal Failure) 09/2019
1	Stillbirth 09/2019
1	Overweight 07/2019
1	Weight Loss (Weight Reduction) 07/2019
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2019
1	Macrocytic Anemia 01/2019
1	Acute-Phase Reaction 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Diabetes Mellitus 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Peripheral Nerve Injuries 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2016
1	Obesity 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2002
9	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 12/2011
7	Insulin (Novolin)FDA Link 01/2021 - 10/2011
7	Pharmaceutical PreparationsIBA 07/2019 - 02/2003
6	AgrinIBA 11/2014 - 07/2007
5	Ribosomal Proteins (Ribosomal Protein)IBA 12/2019 - 12/2008
5	Glucose (Dextrose)FDA LinkGeneric 07/2019 - 12/2010
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2006
3	muskIBA 01/2014 - 03/2011
2	Insulin Glargine (Lantus)FDA Link 01/2021 - 01/2018
2	Mechanistic Target of Rapamycin Complex 2IBA 12/2019 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2018 - 10/2014
2	Messenger RNA (mRNA)IBA 01/2018 - 08/2011
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 06/2015
2	Phosphotransferases (Kinase)IBA 01/2016 - 01/2009
2	Hormones (Hormone)IBA 01/2016 - 05/2011
2	LigandsIBA 08/2015 - 03/2007
2	Biological ProductsIBA 01/2014 - 01/2011
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2011 - 01/2009
1	Caveolin 1IBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	InterleukinsIBA 12/2020
1	Troleandomycin (TAO)FDA Link 12/2020
1	Interleukin-17 (Interleukin 17)IBA 12/2020
1	GlucocorticoidsIBA 12/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Dynamin IIIBA 01/2020
1	Therapeutic UsesIBA 10/2019
1	triphenyltetrazoliumIBA 10/2019
1	Dacarbazine (DIC)FDA LinkGeneric 09/2019
1	Exenatide (Byetta)FDA Link 07/2019
1	U1 small nuclear RNAIBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	ribosomal protein S14IBA 01/2019
1	CollagenIBA 01/2018
1	InterferonsIBA 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	Gliclazide (Diamicron)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 01/2016

Therapy/Procedure

12	Therapeutics 01/2020 - 01/2009
5	Glycemic Control 07/2019 - 12/2014
3	Denervation 03/2013 - 11/2006
1	Aftercare (After-Treatment) 12/2020
1	Ligation 10/2019